9 News Series Explores Leukine, a Drug in Trial to Potentially Slow or Prevent Alzheimer’s Disease
Huntington Potter, Ph.D., is Director of Alzheimer’s Research at the Linda Crnic Institute for Down Syndrome; one of his many accomplishments in his distinguished careers is discovering the mechanistic relationship between Alzheimer’s disease and Down syndrome. Dr. Potter and his lab at the Rocky Mountain Alzheimer’s Disease Center, a Global affiliate, are conducting a clinical trial of the FDA-approved drug Leukine to determine whether it is safe and can help slow or prevent the progression of Alzheimer’s. This journey is the focus of a new series on Channel 9 News:
Tuesday, February 28, 2017
Wednesday, March 1, 2017
Thursday, March 2, 2017
Friday, March 3, 2017
Experience our inspirational and groundbreaking videos and photos. Our children and self-advocates are beautiful AND brilliant!
Make sure your local Representatives are on the Congressional Down Syndrome Task Force.
Keep up with research news, upcoming programs, events and educational conferences.
Find us online here: